All News #Library
Biotech
ENA Doses First Patients in INNA-051 Nasal Phase II Trial
29 Jan 2026 //
PHARMIWEB
ENA Respiratory Secures $22.4M For INNA-051 Nasal Spray Phase II
22 Oct 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support